| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.5B | $17.5B | $15.9B | $14.0B | $14.7B | $3.7B | $3.9B | $3.3B |
| Cost of Revenue | — | — | — | — | — | — | $1.1B | $0.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.7B | $1.4B | $1.4B | $1.0B | $1.6B | $0.4B | $0.2B | $-0.2B |
| EPS (Basic) | $7.98 | $6.42 | $6.30 | $4.17 | $6.08 | $1.45 | $3.08 | $1.99 |
| EPS (Diluted) | $7.97 | $6.41 | $6.29 | $4.16 | $6.07 | $1.45 | $3.07 | $1.99 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $86.3B | $81.9B | $79.2B | $75.5B | $81.6B | $80.2B | $82.2B | $78.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.5B | $0.4B | $0.5B | $0.6B | $0.5B | $0.3B | $0.4B |
| Total Liabilities | $66.7B | $64.0B | $62.7B | $60.0B | $62.5B | $61.1B | $60.3B | $56.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $18.7B | $17.1B | $15.7B | $14.6B | $17.8B | $17.9B | $19.1B | $18.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $3.0B | $3.9B | $3.3B | $2.6B | $1.7B | $1.7B | $4.2B |
| Investing Cash Flow | $-2.8B | $-2.0B | $-2.7B | $-2.3B | $-1.2B | $-1.4B | $-0.7B | $-1.4B |
| Capital Expenditures | $0.6B | $0.6B | $0.7B | $0.7B | $0.5B | $0.7B | $1.0B | $1.0B |
| Financing Cash Flow | $-0.5B | $-0.9B | $-1.3B | $-1.0B | $-1.3B | $-0.2B | $-1.1B | $-2.8B |